Evidence map›Paper›PMID 27634526›Full record

ArticleScience (New York, N.Y.)2016

Virulence factors enhance Citrobacter rodentium expansion through aerobic respiration.

Christopher A Lopez, Brittany M Miller, Fabian Rivera-Chávez, Eric M Velazquez, Mariana X Byndloss, Alfredo Chávez-Arroyo, Kristen L Lokken, Renée M Tsolis, Sebastian E Winter, Andreas J Bäumler

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed
18.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 193 citations in OpenAlex.

  1. Gut microbes · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. EnterohemorrhagiciScience · 2026
    Article
  9. Review
  10. Article
  11. Infection strategies ofGut microbes reports · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Christopher A LopezDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA, USA.
Brittany M MillerDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA, USA.
Fabian Rivera-ChávezDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA, USA.
Eric M VelazquezDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA, USA.
Mariana X ByndlossDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA, USA.
Alfredo Chávez-ArroyoDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA, USA.
Kristen L LokkenDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA, USA.
Renée M TsolisDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA, USA.
Sebastian E WinterDepartment of Microbiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, USA.
Andreas J BäumlerDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA, USA. ajbaumler@ucdavis.edu.
University of California, Davis · USThe University of Texas Southwestern Medical Center · US

Funding

UC Davis Biology ProgramR25GM056765 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI GOMES, ALDRIN V. · 1998 to 2019
$9.7M
Virulence Factors of SalmonellaR01AI044170 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BAUMLER, ANDREAS J · 1999 to 2022
$8.5M
Microbiota Outgrowth by SalmonellaR01AI096528 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMLER, ANDREAS J · 2011 to 2025
$6.1M
Mechanism of Colonization ResistanceR01AI112949 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Andreas J Baumler · 2016 to 2026
$5.2M
Pathogenesis of Salmonella bacteremiaR01AI098078 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TSOLIS, RENEE M · 2012 to 2016
$1.8M
Students Training in Advanced Research (STAR) ProgramT35OD010956 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DANIKA L BANNASCH · 2012 to 2026
$1.6M
Salmonella Host interactionsR37AI044170 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Andreas J Baumler, Renee M Tsolis · 2025 to 2026
$1.2M
Year-Long Exposure to Advanced Research (YEAR) Program for Vet StudentsT32OD010931 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RAYBOULD, HELEN E · 2012 to 2018
$752k
Mechanism of dysbiosis caused by AE PathogensR21AI117940 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMLER, ANDREAS J · 2015 to 2016
$431k
Nitrate respiration by Salmonella during gut inflammationR21AI103248 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI WINTER, SEBASTIAN E · 2013 to 2014
$422k
Adherent Invasive E. coli and colitisR21AI107393 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMLER, ANDREAS J · 2013 to 2014
$410k
Pathogenesis of Salmonella BacteremiaR56AI098078 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TSOLIS, RENEE M · 2018 to 2018
$384k
NIAID NIH HHS F31 AI112241NIAID NIH HHS R01 AI044170NIAID NIH HHS R01 AI096528NIAID NIH HHS R01 AI098078NIAID NIH HHS R01 AI112949NIAID NIH HHS R21 AI103248NIAID NIH HHS R21 AI107393NIAID NIH HHS R21 AI117940NIAID NIH HHS R37 AI044170NIAID NIH HHS R56 AI098078NIAID NIH HHS R56 AI112949NIGMS NIH HHS R25 GM056765NIH HHS T32 OD010931NIH HHS T35 OD010956
6 · The paper itself

Abstract

Citrobacter rodentium uses a type III secretion system (T3SS) to induce colonic crypt hyperplasia in mice, thereby gaining an edge during its competition with the gut microbiota through an unknown mechanism. Here, we show that by triggering colonic crypt hyperplasia, the C. rodentium T3SS induced an excessive expansion of undifferentiated Ki67-positive epithelial cells, which increased oxygenation of the mucosal surface and drove an aerobic C. rodentium expansion in the colon. Treatment of mice with the γ-secretase inhibitor dibenzazepine to diminish Notch-driven colonic crypt hyperplasia curtailed the fitness advantage conferred by aerobic respiration during C. rodentium infection. We conclude that C. rodentium uses its T3SS to induce histopathological lesions that generate an intestinal microenvironment in which growth of the pathogen is fueled by aerobic respiration.

Indexed as

AerobiosisAmyloid Precursor Protein SecretasesAnimalsCitrobacter rodentiumColitisColonCytochromesDibenzazepinesElectron Transport Chain Complex ProteinsEnterobacteriaceae InfectionsGene DeletionHyperplasiaIntestinal MucosaKi-67 AntigenMiceMice, Inbred C3HAmyloid Precursor Protein SecretasesCytochromesdibenzazepineDibenzazepinesElectron Transport Chain Complex ProteinsKi-67 AntigenNitratesOxidoreductasesReceptors, NotchVirulence Factors

Identifiers

PMID27634526
PMCPMC5127919
OpenAlexW2519607762

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.